13.07.2018 Drägerwerk AG & Co. KGaA  DE0005550602

DGAP-Adhoc: Drägerwerk AG & Co. KGaA: preliminary result for the first half year


 
DGAP-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results Drägerwerk AG & Co. KGaA: preliminary result for the first half year 13-Jul-2018 / 17:33 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Based on preliminary figures, Drägerwerk AG & Co. KGaA recorded net of currency effects a 1.4 percent (nominally -1.6 percent) increase in order intake year-on-year in the second quarter of 2018. Net sales increased net of currency effects by 10.1 percent (nominally 6.7 percent) to roughly EUR 620 million (Q2 2017: EUR 581.0 million). Despite the higher net sales volume, the EBIT for the quarter stood at about EUR 3 million, significantly below the level of the prior-year quarter (Q2 2017: EUR 16.8 million). This was due in particular to a lower gross profit margin of roughly 43.3 percent (Q2 2017: 44.4 percent) and higher functional expenses. In addition to negative currency effects, higher quality costs and a negative product mix burdened the gross profit margin. For the first half of the year, this resulted in a year-on-year increase in order intake of 2.0 percent net of currency effects (nominally -2.2 percent). The regions Europe and particularly Africa, Asia, and Australia recorded higher order intake net of currency effects compared to the prior-year period. By contrast, in the region Americas order intake was roughly 2 percent (net of currency effects) below the level of the prior-year. Nominally, net sales of the Dräger group stood at about EUR 1,115 million and was on par with the level of the prior-year (6 months 2017: EUR 1,116.0 million). This corresponds to a net sales growth net of currency effects of roughly 4 percent. The gross margin was roughly 42.5 percent (6 months 2017: 44.6 percent). Compared to the prior-year period, functional expenses increased net of currency effects by 9.5 percent (nominally 6.7 percent) in the first half of 2017. Due to the negative earnings in the first quarter, EBIT for the six months period stood at only roughly EUR -37 million (6 months 2017: EUR 19.1 million), corresponding to an EBIT margin of roughly -3.3 percent (6 months 2017: 1.7 percent). Despite the negative earnings in the first six months, the full-year guidance remains unchanged. For the full-year, Dräger continues to expect net sales growth (net of currency effects) of between 2.0 and 5.0 percent and an EBIT margin of between 4.0 and 6.0 percent. The EBIT margin is likely to come out in the lower range of the guidance. Dräger will publish final results for the first six months of 2018 on July 26, 2018. Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23558 Lübeck, Deutschland www.draeger.com Investor Relations: Thomas Fischler Tel. +49 451 882-2685 [email protected] Corporate Communications: Melanie Kamann Tel. +49 451 882-3998 [email protected] --------------------------------------------------------------------------- 13-Jul-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23542 Lübeck Germany Phone: +49 (0)451 882-0 Fax: +49 (0)451 882-2080 E-mail: [email protected] Internet: www.draeger.com ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9 WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D Indices: TecDAX Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange End of Announcement DGAP News Service --------------------------------------------------------------------------- 704585 13-Jul-2018 CET/CEST


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 2.572,26 2.595,01 2.780,82 3.406,78 3.328,42 3.045,23 3.375,50
EBITDA1,2 240,00 147,91 193,71 521,07 421,00 55,80 315,00
EBITDA-Marge3 9,33 5,70 6,97 15,30 12,65 1,83
EBIT1,4 155,74 62,65 66,58 396,60 271,68 -88,61 166,43
EBIT-Marge5 6,05 2,41 2,39 11,64 8,16 -2,91 4,93
Jahresüberschuss1 98,50 34,90 33,79 249,89 154,27 -63,64 111,99
Netto-Marge6 3,83 1,34 1,22 7,34 4,64 -2,09 3,32
Cashflow1,7 143,34 4,09 164,42 459,98 384,89 -144,23 189,68
Ergebnis je Aktie8 4,12 1,42 1,38 10,19 7,13 -3,41 5,86
Dividende8 0,40 0,13 0,13 0,13 0,13 0,13 0,13
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: -

INVESTOR-INFORMATIONEN
©boersengefluester.de
Drägerwerk ST
WKN Kurs in € Einschätzung Börsenwert in Mio. €
555060 44,300 Kaufen 886,97
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
8,20 17,22 0,47 12,06
KBV KCV KUV EV/EBITDA
0,61 4,38 0,26 3,54
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,13 1,74 3,93 08.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
25.04.2024 25.07.2024 29.10.2024 07.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,23% 5,07% -0,89% 12,72%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Drägerwerk AG & Co. KGaA  ISIN: DE0005550602 können Sie bei EQS abrufen


Medtech , 555060 , DRW8 , XETR:DRW8